UCB SA (UCB.BR) Stock Price

€136.3 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    3

  • Fundamental

    8

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on UCB SA, AI stock picks, stock alerts and much more.

Sign up

UCB.BR AI Stock Analysis

AI stock analysis for UCB.BR is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like UCB SA (UCB.BR) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

UCB SA (UCB.BR) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of UCB SA (UCB.BR), currently trading at €136.3, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About UCB.BR

LSE

  • UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases.

  • Symbol

    UCB.BR

  • Market

    EURONEXT

  • Industry

    Biotechnology

  • Market Cap

    25.9B

Similar Stocks

VLA.PA Valneva SE
VLA.PA		 €3.04
1.1%
5
TUB.BR Financière de Tubize SA
TUB.BR		 €110.2
1.3%
6
OSE.PA OSE Immunotherapeutics SA
OSE.PA		 €5.9
1%
7
IPH.PA Innate Pharma S.A.
IPH.PA		 €1.75
0.5%
4
PHARM.AS Pharming Group
PHARM.AS		 €0.701
0.9%
5

News

Pictet Asset Management Holding SA Invests $471,000 in United Community Banks, Inc. (NASDAQ:UCB)

Pictet Asset Management Holding SA Invests $471,000 in United Community Banks, Inc. (NASDAQ:UCB)
April 10, 2025. ETF Daily News
UCB (OTCMKTS:UCBJY) Stock Price Crosses Below 200 Day Moving Average – Should You Sell?

UCB (OTCMKTS:UCBJY) Stock Price Crosses Below 200 Day Moving Average – Should You Sell?
April 5, 2025. ETF Daily News
UCB SA (OTCMKTS:UCBJF) Short Interest Up 20.8% in March

UCB SA (OTCMKTS:UCBJF) Short Interest Up 20.8% in March
April 1, 2025. ETF Daily News
UCB (OTCMKTS:UCBJY) Shares Pass Above 50-Day Moving Average – Time to Sell?

UCB (OTCMKTS:UCBJY) Shares Pass Above 50-Day Moving Average – Time to Sell?
March 19, 2025. ETF Daily News

UCB.BR Alternative Data

Web Traffic

UCB SA receives an estimated 160996 monthly visitors to ucb.com.

  • Web Traffic

    160996

  • Change from Previous Month

    10.9%

  • 3 Month Change

    3.5%

  • YoY Change

    3.5%

News Mentions

UCB SA was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    0%

Twitter Followers

UCB SA has 10,928 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.

  • Twitter Followers

    10928

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    1.3%

Facebook Engagement

UCB SA has engaged 150 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    150

  • Daily Change

    28.6%

  • 1 Month Change

    525%

  • 3 Month Change

    782.4%

Instagram Followers

UCB SA has 2,271 Instagram Followers on its main Instagram account, up by 0.5% over the last month.

  • Instagram Followers

    2271

  • Daily Change

    0.1%

  • 1 Month Change

    0.5%

  • 3 Month Change

    19%

Youtube Subscribers

UCB SA has 2,550 subscribers on its main Youtube channel, up by 0.8% over the last month.

  • Youtube Subscribers

    2550

  • Daily Change

    0%

  • 1 Month Change

    0.8%

  • 3 Month Change

    2.8%

Job Postings

UCB SA currenly has an estimated 345 open job postings, up by 10.6% over the last month.

  • Job Postings

    345

  • Daily Change

    0.6%

  • 1 Month Change

    10.6%

  • 3 Month Change

    7%

Reddit Mentions

UCB SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

App Downloads

  • App Downloads

    1

  • Daily Change

    50%

  • 1 Month Change

    83.3%

  • 3 Month Change

    50%

LinkedIn Employees

According to LinkedIn, UCB SA has 13,518 employees.

  • LinkedIn Employees

    13518

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    1.4%

Business Outlook

According to employee reviews, the business outlook among employees at UCB SA is 73 out of 100 (bullish).

  • Business Outlook

    73

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

UCB.BR Financials

UCB.BR Key Metrics

  • Total Revenue

    €2.8B

  • Net Income

    €208M

  • Earnings per Share

    €1.1

  • Free cash flow

    €261M

  • EBITDA

    €644M

  • EBITDA Ratio

    0.230742

  • Total Assets

    €17.3B

UCB.BR 2-year Revenue & Income
UCB.BR 2-year Free Cash Flow

UCB.BR Technicals

UCB.BR SMA
UCB.BR RSI

FAQ

What's the current price of UCB SA (UCB.BR) Stock?
The price of an UCB SA (UCB.BR) share is €136.3.

What's the market cap of UCB SA?
The current market cap of UCB SA is 25.9B.

Should I buy or sell UCB.BR?
UCB SA shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, UCB SA is better viewed as a hold or accumulate position while waiting for further developments.

Is UCB SA a good investment?
The current analysis of UCB SA's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in UCB SA's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy UCB SA (UCB.BR) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for UCB SA stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to UCB SA (UCB.BR) that investors often compare it to?
UCB SA (UCB.BR) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, Innate Pharma S.A. and Pharming Group.

What is the forecast for UCB SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast UCB SA's stock price to be around €132.5 in 2026. Starting from the current price of €136.3, this represents a 2.8% change in price, indicating a neutral outlook for the stock.

How to buy UCB SA (UCB.BR) Stock?
UCB SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy UCB SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.